Skip to main content

This year's Nobel Prize in Physics

Logo

The Nobel Prize went to two physicists honored for the discovery that neutrinos have mass.

Their discovery was a major contribution to what is now known as the "standard model" of the elementary particles. Until their turn-of-the-millennium work, the widely shared opinion was that neutrinos (like photons) don't have mass. This consensus had led -- don't ask me why-- to a further consensus on how many of them ought to be detectable on earth. And that, in turn led to some confusion because the quantities actually detected were much smaller than what they 'should' be.

So these are experimenters who managed to clear up a split between other experimenters and theorists. The theory had to be revised so that the experimental results, the actual quantity detected, could be accommodated, and their work showed how that could be done.  A victory for pragmatism in science, the hospitable homeland of pragmatism.

I enjoy this time of year for a number of reasons, not the least of which is that this is the time of the announcement of all the Nobels, when we get to read and think about issues we ordinarily wouldn't, and get updated on the names of the giants in the various fields.

As regulars here know, I regularly mine the awards for at least a couple of blog entries every year.

So: the physicists in question are:  Takaaki Kajita of Japan and Arthur McDonald of Canada  They've followed the usual, "shucks folks, do they mean me?" script. Kajita told a news conference is Japan, "I'm still so shocked I don't really know what to say."

Well, I know what to say. A hearty congratulations to you both.

------------------------

Not worth a post of its own, but something I can't help mentioning -- the prize committee seems to have been split between two different candidates for the Medicine Prize this year, which would explain why the Chemistry Prize ended up going to the development of therapy-oriented genetics. Two Medicine awards, so to speak.

And I'll say something about the Peace Prize later this month.

Comments

Popular posts from this blog

England as a Raft?

In a lecture delivered in 1880, William James asked rhetorically, "Would England ... be the drifting raft she is now in European affairs if a Frederic the Great had inherited her throne instead of a Victoria, and if Messrs Bentham, Mill, Cobden, and Bright had all been born in Prussia?"

Beneath that, in a collection of such lectures later published under James' direction, was placed the footnote, "The reader will remember when this was written."

The suggestion of the bit about Bentham, Mill, etc. is that the utilitarians as a school helped render England ineffective as a European power, a drifting raft.

The footnote was added in 1897. So either James is suggesting that the baleful influence of Bentham, Mill etc wore off in the meantime or that he had over-estimated it.

Let's unpack this a bit.  What was happening in the period before 1880 that made England seem a drifting raft in European affairs, to a friendly though foreign observer (to the older brother…

Cancer Breakthrough

Hopeful news in recent days about an old and dear desideratum: a cure for cancer. Or at least for a cancer, and a nasty one at that.

The news comes about because investors in GlaxoSmithKline are greedy for profits, and has already inspired a bit of deregulation to boot. 

The FDA has paved the road for a speedy review of a new BCMA drug for multiple myeloma, essentially cancer of the bone marrow. This means that the US govt has removed some of the hurdles that would otherwise (by decision of the same govt) face a company trying to proceed with these trials expeditiously. 

This has been done because the Phase I clinical trial results have been very promising. The report I've seen indicates that details of these results will be shared with the world on Dec. 11 at the annual meeting of the American Society of Hematology. 

The European Medicines Agency has also given priority treatment to the drug in question. 

GSK's website identifies the drug at issue as "GSK2857916," althou…

Francesco Orsi

I thought briefly that I had found a contemporary philosopher whose views on ethics and meta-ethics checked all four key boxes. An ally all down the line.

The four, as regular readers of this blog may remember, are: cognitivism, intuitionism, consequentialism, pluralism. These represent the views that, respectively: some ethical judgments constitute knowledge; one important source for this knowledge consists of quasi-sensory non-inferential primary recognitions ("intuitions"); the right is logically dependent upon the good; and there exists an irreducible plurality of good.

Francesco Orsi seemed to believe all of these propositions. Here's his website and a link to one relevant paper:

https://sites.google.com/site/francescoorsi1/

https://jhaponline.org/jhap/article/view/3

What was better: Orsi is a young man. Born in 1980. A damned child! Has no memories of the age of disco!

So I emailed him asking if I was right that he believed all of those things. His answer: three out of …